Articles tagged with Bacteriophages
Researchers have engineered viruses to target specific bacteria, offering a new approach to combatting human disease. The customizable viruses could be used to treat various infections, including those caused by E. coli, Yersinia, and Klebsiella bacteria.
Researchers at Brigham Young University have successfully used bacteriophage to decontaminate human MRSA bacteria from surfaces and fabrics, showing promise in treating the deadly superbug. The findings offer hope in combating antibiotic-resistant MRSA, which can cause serious disease and death.
Researchers at Texas A&M AgriLife Research have discovered a natural cocktail of four bacteriophages that can prevent and treat Pierce's disease in wine grapes. The phage treatment offers an alternative to pesticides for disease control, with promising results in both greenhouse experiments and field testing.
Researchers found phages in 49 out of 50 chicken samples that can transduce antimicrobial resistance genes to E. coli bacteria, highlighting the need for phage therapy and improved disinfection methods.
Researchers found that nearly half of chicken meat samples contained viruses capable of transferring antibiotic resistance genes. Phages were able to transfer resistance to multiple antibiotics, including extended spectrum betalactam antibiotics.
Researchers identified a bacteriophage from Jerusalem sewage that can infect and eliminate Enterococcus faecalis biofilms, a common cause of persistent root canal infections. This phage therapy approach may offer a new solution for combating antibiotic-resistant bacteria.
Scientists at Brigham Young University have developed a natural treatment using phages to protect baby bees from American Foulbrood, a deadly disease that kills off larvae and leads to hive collapse. The researchers identified five phage candidates for honeybee treatment, providing a potential alternative to antibiotics.
Researchers found that phages can force cholera bacteria to give up their virulence in order to survive, making them less fit to cause infection. This discovery suggests a new strategy for treating or preventing cholera using phage therapy.
Researchers have discovered how viruses called bacteriophages can be engineered to target and destroy a range of bacteria, including antibiotic-resistant C. diff, which causes fatal infections in hospitals. The study provides hope for developing an alternative to antibiotics.
Researchers have developed a way to identify isolated pieces of DNA floating outside the bacterial chromosome, which can play important roles in virulence and antibiotic resistance. Extrachromosomal DNA elements, such as phages and plasmids, were found widespread among medically important strains of Staphylococci.
A team of researchers found that a significant portion of life uses different vocabularies where the same word means different things in different organisms. This challenges the long-held assumption of a universal genetic code, with up to 10% of bacteria possessing codon reassignments.
Researchers at the University of Missouri have developed a new method for anthrax detection that can identify anthrax in just five hours, compared to current tests which take 24-48 hours. The new method uses a bioluminescent reporter phage to detect anthrax bacteria and rule out false positives.
A new alternative approach to traditional introductory laboratory courses significantly increases student retention rates. Research published in mBio found that SEA-PHAGES students continued on to their second year at over 90% higher rates than other groups.
A new study at Caltech describes a mechanism for bacterial biofilms to induce the transformation of marine invertebrates from larvae to adults. Researchers discovered that phage tail-like structures, similar to those used by viruses to inject genetic material into bacteria, play a crucial role in this process.
Researchers have isolated viruses that specifically target the highly infectious hospital superbug C. diff, which can cause severe diarrhoea and dehydration. The discovery could lead to a new treatment for this condition, with the potential to revolutionise the way it is treated in clinics.
Researchers at the University of Arizona have identified a dozen new types of unknown viruses infecting different strains of marine bacteria. These bacteriophages play key roles in global processes such as oxygen and carbon cycling, climate patterns, and nutrient availability.
Researchers found that bacteriophages significantly reduce C. difficile cells and toxin production without harming the gut microbiota, offering a potential new therapeutic agent to combat hospital infections. However, some bacteria may develop resistance due to lysogeny, requiring further development to control C. difficile infections.
Researchers discover gut viruses confer antibiotic resistance to bacteria by transferring genes that help them withstand multiple antibiotics, raising concerns about the emergence of superbugs and the need for a new approach to mitigate development of antibiotic resistance
A new study reveals that certain viruses, known as bacteriophages, can hijack the immune systems of bacteria to overcome their defenses. This discovery has significant implications for phage therapy, which could potentially treat bacterial infections resistant to antibiotics.
Scientists have identified a unique phage that acts as a predator, infecting and harming competing bacterial strains in the human intestine. The discovery could lead to new techniques for controlling bacteria in a natural way, opening up questions about the role of phages in shaping gut communities.
Researchers find harmless virus living on skin that naturally targets and kills Propionibacterium acnes bacteria, a major trigger of acne. The discovery offers promising new hope for developing targeted anti-acne therapies.
Scientists have isolated and studied 11 viruses that can infect and kill the acne-causing bacterium P. acnes, potentially paving the way for topical therapies. The study found that these phages share a high degree of similarity in their DNA, making it less likely to develop resistance to phage-based antimicrobial therapy.
Researchers have identified a set of viruses shared among individuals from different parts of the world, which target the gut microbiota. The study found that nearly 80% of these viruses are common to two or more individuals, suggesting a global reservoir of phages attacking our gut bacteria.
Researchers are revisiting bacteriophages as antibacterial agents to combat growing antibiotic resistance. Effective against high bacterial loads, these viruses can target specific bacterial strains without infecting human cells.
New research uses imaging techniques to observe how Vibrio cholerae, the bacterium that causes cholera, kills off its rivals using a spring-loaded poison dagger. The study reveals the Type 6 secretion system's role in this process and has implications for understanding bacterial virulence and potential drug targets.
Researchers developed a rapid test using mass spectrometry to identify Staphylococcus aureus, the bacterium causing staph infections. The test can detect low concentrations of bacteria in just a few hours, reducing manual labor and subjective interpretation.
A new study reveals four distinct configurations of the SBP8a bacteriophage, showing its ability to penetrate anthrax cells and control DNA flow. The discovery provides an initial blueprint for modifying the phage into a detection tool for anthrax and other bioterror agents.
A meta-analysis of bacterial-virus interactions reveals a nested structure, with hard-to-infect bacteria infected by generalist viruses and easy-to-infect bacteria attacked by both generalist and specialist viruses. This discovery could improve predictions of microbial population dynamics and community assembly.
Twelve Washington University students isolated and characterized 18 novel phages, including two from St. Louis, in a research project supported by the Science Education Alliance. The findings provide insights into genome architecture and evolution of mycobacteriophages.
A new company, Fixed Phage Limited, has been launched to commercialize technology developed at the University of Strathclyde to tackle bacterial infections and contamination. The technology uses bacteriophages, naturally occurring viruses that are non-toxic but effective against bacteria.
Rice University scientists analyze how bacteria acquire immunity from disease through the CRISPR system, which uses RNA interference to silence viral genes. The study's findings have implications for biotechnology and drug development.
The University of Pittsburgh has received a total of $2 million in grants from the Howard Hughes Medical Institute (HHMI) to support its precollege and undergraduate science education initiatives. The four-year grants will fund academic programs that encourage high school and undergraduate students to engage in active research, fosteri...
Researchers at Texas A&M University discovered that phages, a type of virus, can destroy bacterial cell walls by producing an enzyme called endolysin. This finding may aid in the development of phage therapy to treat bacterial infections.
Researchers at Texas A&M University have found that certain types of bacteria integrate invading DNA into their genetic makeup to increase their chances of survival. This process allows the bacteria to produce diverse progeny, which is essential for dispersal and adaptation to new environments.
NYU researchers found that Staphylococcus aureus can co-opt bacteriophages to transfer toxic genes to unrelated bacteria, including Listeria monocytogenes. This discovery raises concerns about the potential for bacterial toxin exchange and antibiotic resistance.
Researchers at NIST have identified a small biomolecule that binds specifically to hydroxyapatite, the key crystal structure of teeth and bones. This new peptide can be used as a nondestructive tag to monitor bone and tooth mineralization.
Researchers found that viruses infecting bacteria in the region are unrelated to their counterparts globally, with only 5% shared DNA sequences. This contradicts previous studies suggesting widespread dispersal and uniformity of viral genotypes worldwide.
Scientists discover new viruses that target specific types of bacteria, offering an alternative to conventional antibiotic therapy. The approach has potential to combat antibiotic resistance and superbug infections such as MRSA.
MIT and BU researchers develop modular system to design phages targeting specific bacterial biofilms, achieving high success rates. The technology has potential applications in treating infections and cleaning products.
Researchers De Paepe and Taddei found that bacteriophages exhibit life history trade-offs between survival and reproduction, with rapid reproducers suffering higher casualties outside the host. Two physical parameters account for most of the observed variation in survival, suggesting a fundamental property of evolving entities.
Researchers catalogued and characterized 30 mycobacteriophages, finding 3,357 genes in 1,536 'phamilies' with significant genetic diversity. This discovery has implications for understanding diseases like tuberculosis and leprosy.
Researchers developed a phage-genomics educational platform, attracting high school and undergraduate students to scientific discovery. The study found that simplicity, flexibility, and ownership are key attributes of an effective science program.
A new method for identifying bacteria uses genetically engineered phages that infect target bacteria, releasing biotin-capped phage progeny attached to quantum dots. The resulting phage-quantum dot complexes can be detected and counted using microscopy or spectroscopy, allowing for rapid identification of bacteria.
Researchers have developed a 'nanoshuttle' that uses viral particles to precisely home to disease, where it can perform various functions such as destroying tissue or emitting signals. The system has the potential to deliver stem cells to damaged areas, potentially treating heart disease and cancer.
A team of UCSD biochemists has discovered a mechanism for generating 10 trillion varieties of a single protein, providing a new tool for developing novel drugs. This finding, published in Nature Structural and Molecular Biology, uses the genetic mechanism used by a virus that infects bacteria to create a kaleidoscope of variants.
The US Army's Gamma Phage Assay has been approved by the FDA for human use within the Laboratory Response Network (LRN), enabling early detection of anthrax bioterrorism threats. This test, developed with CDC support, is a classical bacteriological method that uses a virus to identify B. anthracis.
Three marine phages, sequenced from cyanobacteria in low-nutrient oceans, exhibit genes adapted for infecting photosynthetic bacteria. These genes may help the host maintain photosynthesis during infection, and could influence phage ecology and range.
Researchers found that marine viruses, known as cyanophages, require light to attach to and infect cyanobacteria, which are crucial for ocean health. This discovery could lead to more effective methods of controlling harmful algal blooms in the environment.
Phage nucleic acid transport poses a fascinating biophysical problem. Researchers used fluorescently labeled phage DNA to investigate the dynamics of DNA ejection from single phages, demonstrating that release is not an all-or-none process but rather a complex and stepwise process.
Researchers at UCLA have discovered a new mechanism in bacteriophages that allows them to rapidly evolve new variants to target bacterial resistance. This discovery has the potential to create
Researchers found that bacteriophages can rapidly evolve new variants to target resistant bacteria, opening up possibilities for developing dynamic anti-microbial agents. The discovery could provide a renewable resource of smart antibiotics for treating bacterial diseases.
Researchers identified 31 novel polypeptide families that inhibit Staphylococcus aureus growth when expressed in bacteria. They used phage genomics to screen for small molecule inhibitors and found several compounds that inhibited bacterial growth and DNA synthesis.
Scientists have successfully synthesized a bacteriophage genome, paving the way for larger microbes to consume CO2 and pollutants. The Institute for Biological Energy Alternatives aims to harness microbiomes to produce fuels and reduce atmospheric carbon emissions.
Researchers at PhageTech identified phage-derived antimicrobial proteins that inhibit bacterial growth and kill bacteria in diverse ways. The company's technology platform has led to the discovery of novel bacterial targets essential to bacterial growth, which are being screened for small molecule compounds as potential new antibiotics.
Bacteriophage, or phage, previously thought not to be infectious to humans, may be a new target for fighting certain bacteria that produce toxins. Scientists found that phage can transfer toxins and genes between bacteria, transforming harmless microbes into virulent bugs.
Researchers have discovered a new bacteriophage, CEV1, that can efficiently infect and kill E. coli O157:H7 in livestock gut systems. This natural approach could lead to an effective management strategy to eradicate the pathogen from livestock.
The study reveals a vast array of genomic diversity among the ten newly isolated phages, with varying genome lengths and unexpected similarities to bacterial genomes. This discovery challenges traditional classification systems and raises questions about the role of bacteriophages in evolution.
Researchers developed a method using bacteriophages to deliver vaccine components, offering advantages over traditional naked DNA vaccines. The technique has significant production and storage benefits, making it an attractive solution for addressing sudden vaccine demands.
Researchers at the University of Florida have developed a novel approach to curing mice of Vibrio vulnificus, a deadly bacteria that causes flu-like symptoms and can be fatal. The treatment involves using a virus to attack the bacterial source, showing promise as an alternative to antibiotics for treating this disease.
Researchers from the University of Florida College of Medicine have developed a new therapy using bacteriophages to treat Vibrio vulnificus infections. Most mice injected with both the bacterium and a deadly bacteriophage survived what would normally be a fatal infection, demonstrating the effectiveness of this approach.